$167 Million is the total value of Iguana Healthcare Management, LLC's 60 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 72.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RARE | Sell | ULTRAGENYX PHARMACEUTICAL IN | $11,250,000 | -60.4% | 160,000 | -60.0% | 6.72% | +32.9% |
| BIIB | Sell | BIOGEN INC | $9,925,000 | -51.2% | 35,000 | -46.2% | 5.93% | +63.6% |
| MDCO | Sell | MEDICINES CO | $9,334,000 | -38.2% | 275,000 | -31.2% | 5.58% | +107.3% |
| CELG | Sell | CELGENE CORP | $9,260,000 | -40.9% | 80,000 | -46.7% | 5.54% | +98.0% |
| AMGN | Sell | AMGEN INC | $7,311,000 | -60.2% | 50,000 | -54.5% | 4.37% | +33.6% |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $6,729,000 | -63.4% | 55,000 | -63.3% | 4.02% | +22.7% |
| MRK | Sell | MERCK & CO INC | $6,476,000 | -30.8% | 110,000 | -26.7% | 3.87% | +131.9% |
| ZBH | Sell | ZIMMER BIOMET HLDGS INC | $5,160,000 | -76.7% | 50,000 | -70.6% | 3.08% | -21.7% |
| NUVA | Sell | NUVASIVE INC | $4,715,000 | -64.6% | 70,000 | -65.0% | 2.82% | +18.6% |
| DERM | Sell | DERMIRA INC | $4,550,000 | -55.2% | 150,000 | -50.0% | 2.72% | +50.4% |
| ABT | New | ABBOTT LABS | $4,417,000 | – | 115,000 | +100.0% | 2.64% | – |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $4,353,000 | -65.0% | 115,000 | -65.2% | 2.60% | +17.2% |
| OMED | Sell | ONCOMED PHARMACEUTICALS INC | $4,241,000 | -74.4% | 550,000 | -62.1% | 2.54% | -14.2% |
| GKOS | Sell | GLAUKOS CORP | $4,116,000 | -54.6% | 120,000 | -50.0% | 2.46% | +52.3% |
| MZOR | Sell | MAZOR ROBOTICS LTDsponsored ads | $3,836,000 | -62.9% | 175,000 | -56.2% | 2.29% | +24.3% |
| New | ISHARES TRput | $3,371,000 | – | 25,000 | +100.0% | 2.02% | – | |
| Sell | CIGNA CORPORATIONcall | $3,335,000 | -48.8% | 25,000 | -50.0% | 1.99% | +71.5% | |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $3,332,000 | -85.8% | 75,000 | -88.5% | 1.99% | -52.3% |
| MRUS | Sell | MERUS N V | $3,167,000 | -52.7% | 150,000 | -62.5% | 1.89% | +58.5% |
| KTWO | Sell | K2M GROUP HLDGS INC | $3,006,000 | -48.8% | 150,000 | -54.5% | 1.80% | +71.8% |
| ALDR | Sell | ALDER BIOPHARMACEUTICALS INC | $2,912,000 | -40.8% | 140,000 | -6.7% | 1.74% | +98.7% |
| WBA | New | WALGREENS BOOTS ALLIANCE INC | $2,897,000 | – | 35,000 | +100.0% | 1.73% | – |
| ANTM | Sell | ANTHEM INC | $2,875,000 | -54.1% | 20,000 | -60.0% | 1.72% | +53.8% |
| SPNC | Sell | SPECTRANETICS CORP | $2,695,000 | -51.2% | 110,000 | -50.0% | 1.61% | +63.7% |
| AGN | New | ALLERGAN PLC | $2,625,000 | – | 12,500 | +100.0% | 1.57% | – |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $2,529,000 | -83.1% | 175,000 | -73.1% | 1.51% | -43.4% |
| SUPN | Sell | SUPERNUS PHARMACEUTICALS INC | $2,525,000 | -66.0% | 100,000 | -66.7% | 1.51% | +14.1% |
| HWAY | Sell | HEALTHWAYS INC | $2,275,000 | -73.9% | 100,000 | -69.7% | 1.36% | -12.7% |
| New | WALGREENS BOOTS ALLIANCE INCcall | $2,069,000 | – | 25,000 | +100.0% | 1.24% | – | |
| CCXI | Sell | CHEMOCENTRYX INC | $1,998,000 | +10.3% | 270,000 | -10.0% | 1.19% | +269.7% |
| REGN | New | REGENERON PHARMACEUTICALS | $1,836,000 | – | 5,001 | +100.0% | 1.10% | – |
| GILD | Sell | GILEAD SCIENCES INC | $1,790,000 | -81.1% | 25,000 | -79.2% | 1.07% | -36.8% |
| NERV | Sell | MINERVA NEUROSCIENCES INC | $1,763,000 | -72.2% | 150,000 | -66.7% | 1.05% | -6.9% |
| AAAP | New | ADVANCED ACCELERATOR APPLICsponsored ads | $1,606,000 | – | 60,000 | +100.0% | 0.96% | – |
| XLRN | Sell | ACCELERON PHARMA INC | $1,531,000 | -39.6% | 60,000 | -14.3% | 0.92% | +102.4% |
| MYL | New | MYLAN N V | $1,526,000 | – | 40,000 | +100.0% | 0.91% | – |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $1,406,000 | -40.9% | 65,000 | -35.0% | 0.84% | +98.1% |
| LHCG | Sell | LHC GROUP INC | $1,371,000 | -71.4% | 30,000 | -76.9% | 0.82% | -4.2% |
| New | ASTRAZENECA PLCcall | $1,366,000 | – | 50,000 | +100.0% | 0.82% | – | |
| AZN | New | ASTRAZENECA PLCsponsored adr | $1,366,000 | – | 50,000 | +100.0% | 0.82% | – |
| ACRS | New | ACLARIS THERAPEUTICS INC | $1,357,000 | – | 50,000 | +100.0% | 0.81% | – |
| DXCM | New | DEXCOM INC | $1,194,000 | – | 20,000 | +100.0% | 0.71% | – |
| IMMU | Sell | IMMUNOMEDICS INC | $1,101,000 | -43.5% | 300,000 | -50.0% | 0.66% | +89.1% |
| XENT | Sell | INTERSECT ENT INC | $908,000 | -68.2% | 75,000 | -58.3% | 0.54% | +6.9% |
| New | SPDR SERIES TRUSTcall | $888,000 | – | 15,000 | +100.0% | 0.53% | – | |
| ARRY | Sell | ARRAY BIOPHARMA INC | $879,000 | -67.4% | 100,000 | -75.0% | 0.52% | +9.1% |
| HZNP | New | HORIZON PHARMA PLC | $809,000 | – | 50,000 | +100.0% | 0.48% | – |
| SCYX | SCYNEXIS INC | $798,000 | -17.6% | 250,000 | 0.0% | 0.48% | +175.7% | |
| RARX | New | RA PHARMACEUTICALS INC | $760,000 | – | 50,000 | +100.0% | 0.45% | – |
| AKAOQ | New | ACHAOGEN INC | $651,000 | – | 50,000 | +100.0% | 0.39% | – |
| DPLO | New | DIPLOMAT PHARMACY INC | $630,000 | – | 50,000 | +100.0% | 0.38% | – |
| AXDX | Sell | ACCELERATE DIAGNOSTICS INC | $623,000 | -84.8% | 30,000 | -80.0% | 0.37% | -49.0% |
| MYOV | New | MYOVANT SCIENCES LTD | $622,000 | – | 50,000 | +100.0% | 0.37% | – |
| MDRX | Sell | ALLSCRIPTS HEALTHCARE SOLUTN | $613,000 | -89.7% | 60,000 | -86.7% | 0.37% | -65.3% |
| XBI | New | SPDR SERIES TRUSTs&p biotech | $592,000 | – | 10,000 | +100.0% | 0.35% | – |
| PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $570,000 | -78.8% | 150,000 | -50.0% | 0.34% | -28.8% |
| ADMA | Sell | ADMA BIOLOGICS INC | $512,000 | -76.4% | 100,000 | -66.7% | 0.31% | -20.9% |
| ADAP | Sell | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $405,000 | -80.9% | 100,000 | -66.7% | 0.24% | -35.8% |
| ONCOMED PHARMACEUTICALS INCcall | $386,000 | -32.5% | 50,000 | 0.0% | 0.23% | +126.5% | ||
| TNDM | Sell | TANDEM DIABETES CARE INC | $161,000 | -94.3% | 75,000 | -79.7% | 0.10% | -81.0% |
| Exit | ONCOMED PHARMACEUTICALS INCput | $0 | – | -50,000 | -100.0% | -0.10% | – | |
| MEIP | Exit | MEI PHARMA INC | $0 | – | -600,000 | -100.0% | -0.19% | – |
| ESPR | Exit | ESPERION THERAPEUTICS INC NE | $0 | – | -80,000 | -100.0% | -0.20% | – |
| Exit | ESPERION THERAPEUTICS INC NEput | $0 | – | -100,000 | -100.0% | -0.25% | – | |
| EPZM | Exit | EPIZYME INC | $0 | – | -150,000 | -100.0% | -0.26% | – |
| ONCE | Exit | SPARK THERAPEUTICS INC | $0 | – | -25,000 | -100.0% | -0.27% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.28% | – |
| PRAH | Exit | PRA HEALTH SCIENCES INC | $0 | – | -30,000 | -100.0% | -0.30% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -100,000 | -100.0% | -0.40% | – |
| Exit | GILEAD SCIENCES INCcall | $0 | – | -30,000 | -100.0% | -0.42% | – | |
| MGNX | Exit | MACROGENICS INC | $0 | – | -80,000 | -100.0% | -0.43% | – |
| Exit | FIVE PRIME THERAPEUTICS INCput | $0 | – | -50,000 | -100.0% | -0.47% | – | |
| IVTY | Exit | INVUITY INC | $0 | – | -200,000 | -100.0% | -0.49% | – |
| Exit | PHARMERICA CORPput | $0 | – | -100,000 | -100.0% | -0.50% | – | |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.55% | – |
| OPHT | Exit | OPHTHOTECH CORP | $0 | – | -70,000 | -100.0% | -0.58% | – |
| KITE | Exit | KITE PHARMA INC | $0 | – | -60,000 | -100.0% | -0.60% | – |
| ACHC | Exit | ACADIA HEALTHCARE COMPANY IN | $0 | – | -70,000 | -100.0% | -0.62% | – |
| IONS | Exit | IONIS PHARMACEUTICALS INC | $0 | – | -100,000 | -100.0% | -0.65% | – |
| PMC | Exit | PHARMERICA CORP | $0 | – | -150,000 | -100.0% | -0.75% | – |
| BIOS | Exit | BIOSCRIP INC | $0 | – | -1,500,000 | -100.0% | -0.77% | – |
| RTRX | Exit | RETROPHIN INC | $0 | – | -200,000 | -100.0% | -0.80% | – |
| IPXL | Exit | IMPAX LABORATORIES INC | $0 | – | -200,000 | -100.0% | -0.84% | – |
| Exit | AERIE PHARMACEUTICALS INCput | $0 | – | -130,000 | -100.0% | -0.88% | – | |
| FLML | Exit | FLAMEL TECHNOLOGIES SAsponsored adr | $0 | – | -400,000 | -100.0% | -0.88% | – |
| PCRX | Exit | PACIRA PHARMACEUTICALS INC | $0 | – | -150,000 | -100.0% | -0.92% | – |
| Exit | GLOBAL BLOOD THERAPEUTICS INput | $0 | – | -100,000 | -100.0% | -0.94% | – | |
| GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -40,000 | -100.0% | -0.95% | – |
| Exit | LILLY ELI & COcall | $0 | – | -75,000 | -100.0% | -1.07% | – | |
| Exit | GW PHARMACEUTICALS PLCcall | $0 | – | -50,000 | -100.0% | -1.18% | – | |
| BMY | Exit | BRISTOL MYERS SQUIBB CO | $0 | – | -130,000 | -100.0% | -1.25% | – |
| Exit | BIOGEN INCcall | $0 | – | -25,000 | -100.0% | -1.40% | – | |
| EXEL | Exit | EXELIXIS INC | $0 | – | -700,000 | -100.0% | -1.60% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -150,000 | -100.0% | -1.81% | – |
| SHPG | Exit | SHIRE PLCsponsored adr | $0 | – | -65,000 | -100.0% | -2.25% | – |
| Exit | CELGENE CORPcall | $0 | – | -150,000 | -100.0% | -2.80% | – | |
| PFE | Exit | PFIZER INC | $0 | – | -500,000 | -100.0% | -3.02% | – |
| Exit | GW PHARMACEUTICALS PLCput | $0 | – | -130,000 | -100.0% | -3.08% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOGEN INC | 17 | Q1 2018 | 7.5% |
| ULTRAGENYX PHARMACEUTICAL IN | 17 | Q1 2018 | 6.7% |
| MERCK & CO INC NEW | 16 | Q1 2018 | 5.4% |
| CELGENE CORP | 15 | Q4 2017 | 7.9% |
| AERIE PHARMACEUTICALS INC | 15 | Q4 2017 | 3.3% |
| GILEAD SCIENCES INC | 14 | Q1 2017 | 6.7% |
| ESPERION THERAPEUTICS INC NE | 14 | Q1 2018 | 7.8% |
| SUPERNUS PHARMACEUTICALS INC | 14 | Q4 2017 | 2.8% |
| DERMIRA INC | 14 | Q1 2018 | 2.7% |
| AMGEN INC | 13 | Q1 2017 | 6.5% |
View Iguana Healthcare Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-02-14 |
| 13F-HR/A | 2017-11-16 |
| 13F-HR | 2017-11-14 |
| 13F-HR | 2017-08-14 |
| 13F-HR | 2017-05-15 |
| 13F-HR | 2017-02-14 |
| 13F-HR/A | 2016-11-17 |
| 13F-HR | 2016-11-14 |
| 13F-HR/A | 2016-11-04 |
View Iguana Healthcare Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.